Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G9XP
|
|||
Former ID |
DCL001205
|
|||
Drug Name |
LB80380
|
|||
Synonyms |
LB80380; UNII-S9I9P4J8IU; LB 80380; S9I9P4J8IU; LB-80380; 441785-26-8; PMCDG dipivoxil; AC1O59EP; SCHEMBL4270816; CHEMBL1652128; ANA-380; DTXSID90196062; J3.616.617G; [[1-[(2-aminopurin-9-yl)methyl]cyclopropoxy]methyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate; [({[(2-Aminopurin-9-yl)methyl]cyclopropoxy}methyl)[(2,2-dimethylpropanoyloxy)methoxy]carbonyloxy]methyl 2,2-dimethylpropanoate; 872968-04-2
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2b | [1] | |
Company |
LG Life Sciences
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H34N5O8P
|
|||
Canonical SMILES |
CC(C)(C)C(=O)OCOP(=O)(COC1(CC1)CN2C=NC3=CN=C(N=C32)N)OCOC(=O)C(C)(C)C
|
|||
InChI |
1S/C22H34N5O8P/c1-20(2,3)17(28)31-12-34-36(30,35-13-32-18(29)21(4,5)6)14-33-22(7-8-22)10-27-11-25-15-9-24-19(23)26-16(15)27/h9,11H,7-8,10,12-14H2,1-6H3,(H2,23,24,26)
|
|||
InChIKey |
JLKJXDOWBVVABZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 441785-26-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hepatitis B virus Reverse transcriptase (HBV RT) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | 2011 Pipeline of LG Life Sciences. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.